Testing effectiveness (Phase 2)Study completedNCT00260611What this trial is testingStudy of Oxaliplatin and Taxotere in Prostate CancerWho this might be right forProstate Cancer University of Pittsburgh 34
Testing effectiveness (Phase 2)UnknownNCT00121095What this trial is testingStudy of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate CancerWho this might be right forProstatic Neoplasms Cytogen Corporation 69
Early research (Phase 1)Ended earlyNCT05252390What this trial is testingNUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorOvarian CancerOvary Cancer+24 more Nuvation Bio Inc. 82
Testing effectiveness (Phase 2)Study completedNCT00390468What this trial is testingTandutinib in Treating Patients With Progressive Prostate Cancer and Bone MetastasesWho this might be right forMetastatic CancerPainProstate Cancer National Cancer Institute (NCI) 18
Early research (Phase 1)Looking for participantsNCT05997615What this trial is testingSafety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate CancerWho this might be right forHormone-refractory Prostate Cancer Astellas Pharma Global Development, Inc. 437
Early research (Phase 1)Study completedNCT00032825What this trial is testingKetoconazole Plus Docetaxel to Treat Prostate CancerWho this might be right forProstatic Neoplasms National Cancer Institute (NCI) 674
Testing effectiveness (Phase 2)Study completedNCT00083005What this trial is testingDocetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the ProstateWho this might be right forProstate Cancer National Institutes of Health Clinical Center (CC) 60
Testing effectiveness (Phase 2)Study completedNCT00045227What this trial is testingVaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate CancerWho this might be right forProstate Cancer National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00134654What this trial is testingTwo Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate CancerWho this might be right forProstate Cancer Dana-Farber Cancer Institute 48
Large-scale testing (Phase 3)Study completedNCT00065442What this trial is testingProvenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone TherapyWho this might be right forProstate Cancer Dendreon 512
Testing effectiveness (Phase 2)Ended earlyNCT00179738What this trial is testingA Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid, CC-5013) in Subjects With Androgen Independent Prostate Cancer.Who this might be right forProstate Cancer Celgene Corporation 40
Early research (Phase 1)Study completedNCT00186108What this trial is testingA Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate CancerWho this might be right forProstate Cancer Stanford University 23
Testing effectiveness (Phase 2)Study completedNCT00012142What this trial is testingCCI-779 in Treating Patients With Prostate CancerWho this might be right forProstate Cancer Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00436956What this trial is testingAZD2171 to Treat Prostate CancerWho this might be right forProstate Cancer National Cancer Institute (NCI) 59
Testing effectiveness (Phase 2)Ended earlyNCT00536991What this trial is testingCalcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate CancerWho this might be right forProstate AdenocarcinomaRecurrent Prostate CarcinomaStage III Prostate Cancer+1 more Roswell Park Cancer Institute 51
Not applicableWithdrawnNCT00559481What this trial is testingKetoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation TherapyWho this might be right forProstate Cancer Roswell Park Cancer Institute
Early research (Phase 1)Study completedNCT00413322What this trial is testingStudy of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsWho this might be right forTumor Valerio Therapeutics 35
Not applicableUnknownNCT04833517What this trial is testingProspective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)Who this might be right forProstate Cancer MetastaticCastration Resistant Prostatic CancerAdvanced Prostate Carcinoma Universität des Saarlandes 500
Testing effectiveness (Phase 2)Study completedNCT00096499What this trial is testingSB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or PaclitaxelWho this might be right forAdenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00006044What this trial is testingTestosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone TherapyWho this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center